300006 莱美药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-2.473-4.439-0.425-3.210-6.042
总资产报酬率 ROA (%)-1.635-3.056-0.300-2.297-3.310
投入资产回报率 ROIC (%)-1.922-3.623-0.360-2.799-4.112

边际利润分析
销售毛利率 (%)55.33164.38869.33073.49871.466
营业利润率 (%)-8.156-13.3016.278-10.857-5.725
息税前利润/营业总收入 (%)-9.601-11.865-2.123-7.963-7.057
净利润/营业总收入 (%)-7.731-10.066-1.119-8.624-8.646

收益指标分析
经营活动净收益/利润总额(%)97.246115.869-2,145.438151.840119.260
价值变动净收益/利润总额(%)35.24024.9912,421.015-7.682-45.226
营业外收支净额/利润总额(%)0.416-40.090-1,464.312-27.63133.806

偿债能力分析
流动比率 (X)2.0422.2082.9282.4892.590
速动比率 (X)1.8321.9572.6242.2012.353
资产负债率 (%)32.95534.05226.59128.48324.418
带息债务/全部投入资本 (%)21.49720.73611.57914.8407.790
股东权益/带息债务 (%)360.053376.362735.392568.4871,157.975
股东权益/负债合计 (%)201.982192.839270.667244.128301.736
利息保障倍数 (X)6.8015.0050.841-14.654-4.432

营运能力分析
应收账款周转天数 (天)122.477134.811131.612153.285133.152
存货周转天数 (天)194.354236.777244.692276.541233.973